Renal effects of cyclooxygyenase-2-selective inhibitors (Q34126991)

31 July 2017

1 reference

title

Renal effects of cyclooxygyenase-2-selective inhibitors (English)

1 reference

31 July 2017

D Craig Brater

1

1 reference

31 July 2017

1 April 2002

1 reference

Journal of Pain and Symptom Management

31 July 2017

1 reference

31 July 2017

23

1 reference

31 July 2017

4 Suppl

1 reference

31 July 2017

S15-20; discussion S21-3

1 reference

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Renal syndromes associated with nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Nonsteroidal anti-inflammatory drugs: effects on kidney function

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Renal complications of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Differential regulation of renal cyclooxygenase mRNA by dietary salt intake

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Effects of celecoxib and naproxen on renal function in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900370-6

7 January 2021

10.1016/S0885-3924(02)00370-6

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11992745